Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Rxi Pharmaceuticals (RXII)

0.6703 0.017 (2.65%)

12-12 11:02

Open:

0.73

Pre. Close:

0.653

High:

0.73

Low:

0.6611

Volume:

143,399

Market Cap:

16M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.71 - 0.73

0.73 - 0.75

Low:

0.59 - 0.6

0.6 - 0.63

Close:

0.63 - 0.65

0.65 - 0.69

Technical analysis  (as of: 2017-12-12 10:47:00 AM)

Overall:

      

Stoxline posted a STRONG BUY today, same as yesterday. This stock still seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 0.90     One year: 1.05

Support:

Support1: 0.60    Support2: 0.50

Resistance:

Resistance1: 0.77    Resistance2: 0.90

Pivot:

0.63

Moving Averages:

MA(5): 0.62     MA(20): 0.62

MA(100): 0.57     MA(250): 0.64

MACD:

MACD(12,26): 0.01     Signal(12,26,9): 0.01

%K %D:

%K(14,3): 45.70     %D(3): 31.68

RSI:

RSI(14): 60.70

52-Week:

High: 1.75  Low: 0.32  Change(%): -51.0

Average Vol(K):

3-Month: 44230  10-Days 26491

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
RXII has closed below upper band by 27.8%. Bollinger Bands are 40.9% wider than normal. The large width of the bands suggest high volatility as compared to RXII's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue.

Headline News

Mon, 11 Dec 2017 12:00:00 GMT
Medigene Collaborates with RXi Pharmaceuticals to Further Sharpen its ...

Thu, 12 Jan 2017 14:58:55 GMT
RXi Pharmaceuticals Acquires MirImmune For Cancer Immunotherapy Prospects

Wed, 07 Jun 2017 11:03:45 GMT
RXi Pharmaceuticals Corporation Announces the Appointment of Dr. Jonathan ...

Wed, 21 Dec 2016 14:48:45 GMT
RXi Pharmaceuticals Announces Closing of $11.5 Million Underwritten Public ...

Mon, 09 Jan 2017 12:02:56 GMT
RXi Pharmaceuticals Completes Acquisition of MirImmune Inc. and Appoints New ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

23.70

Shares Float (M)

19.26

% Held by Insiders

17.96

% Held by Institutions

2.39

Shares Short (K)

1760

Shares Short Prior Month (K)

1690

Stock Financials

EPS

-0.805

EPS Est. Current Year

-1.770

EPS Est. Next Year

-0.570

EPS Est. Next Quarter

Forward EPS

-0.570

Book Value (p.s.)

0.140

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-111.1

Return on Equity (ttm)

-395.6

Qtrly Rev. Growth

Gross Profit (p.s.)

0.001

Sales Per Share

EBITDA (p.s.)

-0.407

Qtrly Earnings Growth

Operating Cash Flow (M)

-8.69

Levered Free Cash Flow (M)

-5.05

atoplab.com

Valuation

P/E

-0.83

P/E Growth Ratio

0.03

P/BV

4.80

P/S

P/CF

-1.83

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2016-04-18

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.